moxifloxacin has been researched along with Burns in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chhibber, T; Gondil, VS; Sinha, VR | 1 |
| Ahmed Khan, T; Azher, I; Sheikh, AK; Sheikh, M | 1 |
| Ali Buabeid, M; Arafa, EA; Hussain, I; Li, L; Murtaza, G; Shah, A | 1 |
| Dadashzadeh, S; Haeri, A; Mahboubi, A; Mortazavi, A; Sohrabi, S | 1 |
4 other study(ies) available for moxifloxacin and Burns
| Article | Year |
|---|---|
Development of Chitosan-Based Hydrogel Containing Antibiofilm Agents for the Treatment of Staphylococcus aureus-Infected Burn Wound in Mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents, Local; Biofilms; Boswellia; Burns; Chitosan; Drug Compounding; Gels; Hydrogels; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Moxifloxacin; Staphylococcal Infections; Staphylococcus aureus; Wound Infection | 2020 |
Burn aggravated infected wart in a patient with type 2 diabetes: a medical challenge.
Topics: Aged; Anti-Bacterial Agents; Burns; Cefepime; Cephalosporins; Diabetes Mellitus, Type 2; Fluoroquinolones; Foot; Foot Diseases; Humans; Male; Moxifloxacin; Pakistan; Saudi Arabia; Staphylococcal Infections; Staphylococcus aureus; Warts | 2018 |
The wound healing and antibacterial potential of triple-component nanocomposite (chitosan-silver-sericin) films loaded with moxifloxacin.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bandages; Burns; Chitosan; Drug Liberation; Male; Moxifloxacin; Nanocomposites; Rats, Sprague-Dawley; Sericins; Silver; Skin; Skin Absorption; Wound Healing | 2019 |
Chitosan gel-embedded moxifloxacin niosomes: An efficient antimicrobial hybrid system for burn infection.
Topics: Anti-Infective Agents; Burns; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Drug Liberation; Fluoroquinolones; Gels; Infections; Microbial Sensitivity Tests; Moxifloxacin; Particle Size; Spectroscopy, Fourier Transform Infrared; Staphylococcus aureus; Viscosity | 2016 |